Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2026GlobeNewsWire • 04/14/26
Genmab Presents the Safety and Tolerability of Rinatabart Sesutecan (Rina-S®) in Combination with Bevacizumab in Advanced Ovarian CancerBusiness Wire • 04/13/26
Constitution of the Board of Directors in Genmab A/S and Grant of Restricted Stock Units and Warrants to Employees in GenmabGlobeNewsWire • 03/19/26
Genmab A/S (GMAB) Presents at Barclays 28th Annual Global Healthcare Conference TranscriptSeeking Alpha • 03/11/26
Grant of Restricted Stock Units to Management and Employees and Grant of Warrants to Employees in GenmabGlobeNewsWire • 02/27/26
Genmab and AbbVie's blood cancer drug fails to improve survival in late-stage studyReuters • 01/16/26
Genmab Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)Business Wire • 01/16/26